Scarborough Ashley P, Slome Sally, Hurley Leo B, Park Ina U
From the *California STD/HIV Prevention Training Center, University of California San Francisco, San Francisco, CA; †The Permanente Medical Group, Oakland, CA; ‡Kaiser Permanente Northern California Division of Research, Oakland, CA; and §Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA.
Sex Transm Dis. 2015 Oct;42(10):595-8. doi: 10.1097/OLQ.0000000000000333.
Screening for gonorrhea (GC) and chlamydia (CT) and syphilis among HIV-positive (HIV+) men who have sex with men (MSM) is recommended at least annually. However, significant gaps in screening coverage exist. We conducted a quality improvement intervention to determine whether informing providers of preintervention screening rates and routinizing sexual risk assessment would improve sexually transmitted disease (STD) screening in a large HIV care clinic.
In partnership with Kaiser Permanente Northern California, we developed and implemented a 10-item assessment addressing sexual and other behavioral risk factors among HIV+ MSM. We analyzed the proportion of patients screened for GC/CT and syphilis in a preintervention period (June 25-September 26, 2012) and during the intervention period (June 25-September 26, 2013).
Of 364 HIV+ MSM seen for care during the intervention period, 47.3% completed the sexual risk assessment. Improvements in GC/CT screening and syphilis screening were observed; when comparing the preintervention period with the intervention period, the proportion of HIV+ MSM receiving GC/CT screening increased by 26.8% (31.6%-40.1%, P = 0.01) at any anatomical site and by 45% (19.5%-28.3%, P = 0.003) at the pharyngeal site. Syphilis screening significantly increased by 18.8% (48.7%-58.0%, P = 0.009).
Overall STD screening increases were observed after this intervention that included didactic training on the urgency of STD screening needs for HIV+ MSM, a presentation of preintervention clinic STD screening data, and the implementation of self-reported sexual risk assessment. Additional efforts are needed to determine feasible ways to accurately assess the appropriateness of STD screening and success of interventions to improve STD screening.
建议至少每年对男男性行为者(MSM)中的艾滋病毒阳性(HIV+)者进行淋病(GC)、衣原体(CT)和梅毒筛查。然而,筛查覆盖率存在显著差距。我们开展了一项质量改进干预措施,以确定告知医护人员干预前的筛查率并将性风险评估常规化是否会改善一家大型艾滋病毒护理诊所的性传播疾病(STD)筛查情况。
我们与北加利福尼亚州凯撒医疗集团合作,制定并实施了一项包含10个项目的评估,涉及HIV+MSM的性及其他行为风险因素。我们分析了干预前期(2012年6月25日至9月26日)和干预期间(2013年6月25日至9月26日)接受GC/CT和梅毒筛查的患者比例。
在干预期间接受护理的364名HIV+MSM中,47.3%完成了性风险评估。观察到GC/CT筛查和梅毒筛查有所改善;将干预前期与干预期间进行比较时,接受GC/CT筛查的HIV+MSM比例在任何解剖部位均增加了26.8%(从31.6%增至40.1%,P = 0.01),在咽部部位增加了45%(从19.5%增至28.3%,P = 0.003)。梅毒筛查显著增加了18.8%(从48.7%增至58.0%,P = 0.009)。
在此次干预后观察到性传播疾病总体筛查率有所提高,该干预包括针对HIV+MSM性传播疾病筛查需求紧迫性的教学培训、展示干预前诊所性传播疾病筛查数据以及实施自我报告的性风险评估。还需要进一步努力确定可行的方法,以准确评估性传播疾病筛查的适宜性以及改善性传播疾病筛查干预措施的成效。